[1]刘 阳,许汴菊△.醋酸亮丙瑞林微球在子宫腺肌病合并不孕患者行体外受精-胚胎移植治疗中的应用*[J].陕西医学杂志,2020,49(2):223-226.
　LIU Yang,XU Bianju..Application of Leuprolide acetate microsphere in the treatment of adenomyosis combined with infertility in patients undergoing IVF-ET[J].,2020,49(2):223-226.
点击复制

醋酸亮丙瑞林微球在子宫腺肌病合并不孕患者行体外受精-胚胎移植治疗中的应用*
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年2期
页码:
223-226
栏目:
药物与临床
出版日期:
2020-02-05

文章信息/Info

Title:
Application of Leuprolide acetate microsphere in the treatment of adenomyosis combined with infertility in patients undergoing IVF-ET
文章编号:
DOI:〖HT5K〗10.3969/j.issn.10007377.2020.02.026
作者:
刘 阳; 许汴菊△
陕西省榆林市第一医院妇产科(榆林719000)
Author(s):
LIU Yang; XU Bianju.
Department of Obstetrics and Gynecology,the First Hospital of Yulin City,Shaanxi Province(Yulin 719000)
关键词:
醋酸亮丙瑞林微球;  子宫腺肌病;  不孕;  治疗;  体外受精-胚胎移植;  妊娠结局
Keywords:
Leuprolide acetate microsphere;  Adenomyosis;  Infertility;  Therapy;  In vitro fertilization-embryo transplantation;  Pregnancy outcome
分类号:
R711.6
文献标志码:
A
摘要:
目的:探讨醋酸亮丙瑞林微球(贝依)在子宫腺肌病合并不孕患者行体外受精-胚胎移植(IVF-ET)治疗中的应用。方法:64例行IVF-ET治疗的不孕患者,其中30例由于输卵管因素与其他因素引起不孕的子宫正常者为对照组,34例因子宫腺肌病伴有不孕者为研究组,分析研究组给予贝依后的疗效并对比两组行IVF-ET治疗的疗效。结果:研究组治疗后子宫体积[(84.24±23.74)cm3]小于治疗前[(179.35±35.85)cm3](t=12.90,P<0.01); 两组临床妊娠率、胚胎种植率、流产率对比均无统计学差异(P>0.05); 研究组治疗后妊娠成功者的双原核率、受精率与优质胚胎率均较妊娠失败者高(P<0.05)。结论:贝依可以有效改善子宫腺肌病合并不孕患者的子宫体积,对其进行IVF-ET治疗可以改善其妊娠结局。
Abstract:
Objective:To investigate the application of leuprolide acetate microspheres(Bey)in the treatment of adenomyosis combined with infertility in vitro fertilization-embryo transfer(IVF-ET).Methods:64 cases of infertility patients were treated with IVF-ET,of which 30 cases of normal uterus with tubal factors and other factors led to the infertility were used as the control group,and 34 cases of adenomyosis complicated with infertility were used as the study group.The curative effect after the treatment of Bey in the study group was analyzed and the curative effect after the treatment of IVF-ET was compared between the two groups.Results:The uterine volume [(84.24±23.74)cm3] of the study group after treatment was smaller than that before treatment [(179.35±35.85)cm3](t=12.90,P<0.01).The clinical pregnancy rate,embryo implantation rate,and abortion rate were compared between the two groups,and there were no statistical differences(P>0.05).After treatment,the rates of double pronuclei,fertilization,and high-quality embryos in patients with successful pregnancy were higher than those in patients with failed pregnancy(P <0.05).Conclusion:Bey can effectively improve the uterine volume of patients with adenomyosis combined with infertility,and IVF-ET treatment can improve their pregnancy outcomes.

参考文献/References:

[1] 刘晓敏,卫 兵.子宫腺肌病和不孕关系的研究进展[J].现代妇产科进展,2012,21(11):904-905,907.
[2] Gunnala V,Melnick A,Irani M,et al.Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome:Analysis of 10,427 IVF-ICSI cycles[J].PLoS One,2017,12(4):e017-019.
[3] 成文俊.注射用醋酸亮丙瑞林微球治疗子宫腺肌病合并不孕的临床研究[J].中国妇幼健康研究,2016,27(S2):148-149.
[4] Diaz GC,Gomez-Gonzalez B,Salinas E,et al.Leuprolide acetate induces structural and functional recovery of injured spinal cord in rats[J].Neural Regen Res,2015,10(11):1819-1824.
[5] 储勇伟.子宫腺肌病与子宫肌瘤特点比较分析[J].临床和实验医学杂志,2013,12(19):1582-1583.
[6] Kaya A,Cayir A,Turan MI,et al.An examination of the effects of leuprolide acetate used in the treatment of central precocious puberty on bone mineral density and 25-hydroxy vitamin D[J].West Indian Med J,2015,64(2):104-107.
[7] Bildik G,Akin N,Senbabaoglu F,et al.GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro[J].Hum Reprod,2015,30(12):2912-2925.
[8] 夏丽群,朱海斌,夏雅仙.子宫腺肌病小鼠模型建立及对生育力的影响[J].中国妇幼健康研究,2013,24(5):672-673,694.
[9] Thalluri V,Tremellen KP.Ultrasound diagnosed adenomyo sis has a negative impact on successful implantation following GnRH antagonist IVF treatment[J].Hum Rep rod,2012,27(12):3487-3492.
[10] Guzman-Soto I,Salinas E,Quintanar JL.Leuprolide acetate inhibits spinal cord inflammatory response in experimental autoimmune encephalomyelitis by suppressing NF-kB activation[J].Neuroimmunomodulation,2016,23(1):33-40.
[11] 李 雷,冷金花.子宫腺肌病对生育影响及治疗研究进展[J].中国实用妇科与产科杂志,2012,28(12):953-955.
[12] Check JH,Wilson C,Levine K,et al.Improved implantation and live delivered pregnancy rates following transfer of embryos derived from donor oocytes by single injection of leuprolide in mid-luteal phase[J].Clin Exp Obstet Gynecol,2015,42(4):429-430.
[13] 苗群英,王佩红,赵 莉,等.汉中市不孕症患者病因调查分析[J].陕西医学杂志,2016,45(8):1094-1096.
[14] Check JH,Wilson C,Cohen R,et al.Mid-luteal phase injection of subcutaneous leuprolide acetate improves live delivered pregnancy and implantation rates in younger women undergoing in vitro fertilization-embryo transfer(IVF-ET)[J].Clin Exp Obstet Gynecol,2015,42(4):427-428.
[15] 张俊娣,郝桂敏,王少卿,等.两种促超排卵方案在体外受精-胚胎移植中的应用[J].河北医药,2016,38(11):1673-1675.
[16] 叶 青,侯 晓,张福霞,等.子宫腺肌病发病相关因素及中医证候探讨[J].中国中医基础医学杂志,2012,18(2):139-141.
[17] Kiba A,Banno K,Yanokura M,et al.Differential mRNA expression profiling in ovarian endometriotic tissue with versus without leuprolide acetate treatment[J].J Obstet Gynaecol Res,2015,41(10):1598-1606.
[18] Guo Y,Duan H,Cheng J,et al.Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis:a clinical study[J].BJOG,2017,124(Suppl 3):7-11.
[19] Matsushima T,Akira S,Asakura H,et al.Low-dose gonadotropin-releasing hormone agonist therapy(draw-back therapy)for successful long-term management of adenomyosis associated with cerebral venous and sinus thrombosis from low-dose oral contraceptive use[J].Clin Exp Obstet Gynecol,2017,44(1):143-145.

备注/Memo

备注/Memo:
*国家自然科学基金资助项目(81871182)
更新日期/Last Update: 2020-03-25